Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease

The aim of the present study was to explore the influence of age and gender, on the association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and plasma total homocysteine (tHcy) concentrations in patients with cardiovascular disease (CVD). Fasting tHcy and the MTHFR C67...

Full description

Bibliographic Details
Main Authors: Houcher Zahira, Houcher Bakhouche, Touabti Abderezak, Begag Samia, Öztürk Ayşenur, Egin Yonca, Akar Nejat, Djabi Farida
Format: Article
Language:English
Published: De Gruyter 2010-02-01
Series:Pteridines
Subjects:
Online Access:https://doi.org/10.1515/pteridines.2010.21.1.103
_version_ 1830190618347831296
author Houcher Zahira
Houcher Bakhouche
Touabti Abderezak
Begag Samia
Öztürk Ayşenur
Egin Yonca
Akar Nejat
Djabi Farida
author_facet Houcher Zahira
Houcher Bakhouche
Touabti Abderezak
Begag Samia
Öztürk Ayşenur
Egin Yonca
Akar Nejat
Djabi Farida
author_sort Houcher Zahira
collection DOAJ
description The aim of the present study was to explore the influence of age and gender, on the association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and plasma total homocysteine (tHcy) concentrations in patients with cardiovascular disease (CVD). Fasting tHcy and the MTHFR C677T mutation were evaluated in 98 patients with CVD, 46 were men and 52 women (aged 20-96 years). There was a significant elevation of plasma tHcy with age (<45 yr: 33.9 μmol/L vs. >75 yr: 43.6 μmol/L; p <0.01). The mean tHcy concentration increased significantly with age in men (<55 yr: 33.4 μmol/L vs. >55yr: 42.45 μmol/L; p 0.01). However, the plasma tHcy was not increased with older age in women. The frequency of the TT genotype was 19.6% in the younger patients group (>55 yr) compared with 4.7% in the older patients group (>55 yr; p <0.01). In conclusion, the data presented here are consistent with genetic factors that influence tHcy levels being more prominent in old patients (>55 yr). Then, the MTHFR mutation does not seem to be associated with either high tHcy or the occurrence of CVD.
first_indexed 2024-12-17T23:24:47Z
format Article
id doaj.art-fe08ff39c87b4f10832a4262fbc3fcdf
institution Directory Open Access Journal
issn 0933-4807
2195-4720
language English
last_indexed 2024-12-17T23:24:47Z
publishDate 2010-02-01
publisher De Gruyter
record_format Article
series Pteridines
spelling doaj.art-fe08ff39c87b4f10832a4262fbc3fcdf2022-12-21T21:28:48ZengDe GruyterPteridines0933-48072195-47202010-02-0121110310910.1515/pteridines.2010.21.1.103Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular DiseaseHoucher Zahira0Houcher Bakhouche1Touabti Abderezak2Begag Samia3Öztürk Ayşenur4Egin Yonca5Akar Nejat6Djabi Farida7Department of Biology, Faculty of Sciences, University of Sétif, SétifDepartment of Biology, Faculty of Sciences, University of Sétif, Sétif, AlgeriaDepartment of Medicine, Faculty of Medical Sciences; University of Sétif, Sétif, AlgeriaDepartment of Biology, Faculty of Sciences, University of Sétif, SétifPediatric Molecular Genetics Department of Ankara University Medical School, Ankara, TurkeyPediatric Molecular Genetics Department of Ankara University Medical School, Ankara, TurkeyPediatric Molecular Genetics Department of Ankara University Medical School, Ankara, TurkeyDepartment of Medicine, Faculty of Medical Sciences; University of Sétif, Sétif, AlgeriaThe aim of the present study was to explore the influence of age and gender, on the association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and plasma total homocysteine (tHcy) concentrations in patients with cardiovascular disease (CVD). Fasting tHcy and the MTHFR C677T mutation were evaluated in 98 patients with CVD, 46 were men and 52 women (aged 20-96 years). There was a significant elevation of plasma tHcy with age (<45 yr: 33.9 μmol/L vs. >75 yr: 43.6 μmol/L; p <0.01). The mean tHcy concentration increased significantly with age in men (<55 yr: 33.4 μmol/L vs. >55yr: 42.45 μmol/L; p 0.01). However, the plasma tHcy was not increased with older age in women. The frequency of the TT genotype was 19.6% in the younger patients group (>55 yr) compared with 4.7% in the older patients group (>55 yr; p <0.01). In conclusion, the data presented here are consistent with genetic factors that influence tHcy levels being more prominent in old patients (>55 yr). Then, the MTHFR mutation does not seem to be associated with either high tHcy or the occurrence of CVD.https://doi.org/10.1515/pteridines.2010.21.1.103hyperhomocysteinemiamethylenetetrahydrofolate reductasec677t polymorphismcardiovascular diseaseagesexalgeria
spellingShingle Houcher Zahira
Houcher Bakhouche
Touabti Abderezak
Begag Samia
Öztürk Ayşenur
Egin Yonca
Akar Nejat
Djabi Farida
Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease
Pteridines
hyperhomocysteinemia
methylenetetrahydrofolate reductase
c677t polymorphism
cardiovascular disease
age
sex
algeria
title Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease
title_full Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease
title_fullStr Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease
title_full_unstemmed Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease
title_short Hyperhomocysteinemia and C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene in Patients with Cardiovascular Disease
title_sort hyperhomocysteinemia and c677t polymorphism of methylenetetrahydrofolate reductase gene in patients with cardiovascular disease
topic hyperhomocysteinemia
methylenetetrahydrofolate reductase
c677t polymorphism
cardiovascular disease
age
sex
algeria
url https://doi.org/10.1515/pteridines.2010.21.1.103
work_keys_str_mv AT houcherzahira hyperhomocysteinemiaandc677tpolymorphismofmethylenetetrahydrofolatereductasegeneinpatientswithcardiovasculardisease
AT houcherbakhouche hyperhomocysteinemiaandc677tpolymorphismofmethylenetetrahydrofolatereductasegeneinpatientswithcardiovasculardisease
AT touabtiabderezak hyperhomocysteinemiaandc677tpolymorphismofmethylenetetrahydrofolatereductasegeneinpatientswithcardiovasculardisease
AT begagsamia hyperhomocysteinemiaandc677tpolymorphismofmethylenetetrahydrofolatereductasegeneinpatientswithcardiovasculardisease
AT ozturkaysenur hyperhomocysteinemiaandc677tpolymorphismofmethylenetetrahydrofolatereductasegeneinpatientswithcardiovasculardisease
AT eginyonca hyperhomocysteinemiaandc677tpolymorphismofmethylenetetrahydrofolatereductasegeneinpatientswithcardiovasculardisease
AT akarnejat hyperhomocysteinemiaandc677tpolymorphismofmethylenetetrahydrofolatereductasegeneinpatientswithcardiovasculardisease
AT djabifarida hyperhomocysteinemiaandc677tpolymorphismofmethylenetetrahydrofolatereductasegeneinpatientswithcardiovasculardisease